Drug Profile
Ipazilide
Alternative Names: WIN 54177; WIN 541774Latest Information Update: 06 Aug 2002
Price :
$50
*
At a glance
- Originator Sanofi Winthrop
- Class Class III antiarrhythmics; Pyrazoles; Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias